Bedside Snapshot
- Normal (Adult)
- 2.5–4.5 mg/dL (0.81–1.45 mmol/L)
Lab-specific; intervals differ by lab - Critical Values
- <1 mg/dL (<0.32 mmol/L) low; no universal high value, high call is lab-specific
- High Suggests
- Kidney failure, AKI or oliguria
- Rhabdomyolysis or tumor lysis
- Phosphate load from IV products or enemas
- Hemolyzed sample (falsely high)
- Low Suggests
- Refeeding after starvation or poor intake
- DKA or HHS treatment with insulin
- Chronic alcohol or drug use
- Prolonged poor intake
- Act Now If
- Low phosphate with weakness, breathing failure or cardiac compromise: monitor, check K⁺, Mg²⁺ and calcium, replace per protocol with medical direction
- Watch Out For
- Refeeding with no phosphate level drawn: check phosphate, K⁺ and Mg²⁺ before calories or dextrose; ASPEN suggests every 12 hr for 3 days in high-risk patients
Reference & Critical Ranges
Lab-specific ranges: Every lab sets its own range. Intervals vary by lab, analyzer and population. Read the range on your report. The values below are typical only.
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adult | 2.5–4.5 mg/dL | 0.81–1.45 mmol/L | Serum. The adult interval cited in the ASPEN 2020 refeeding consensus; the lab range governs |
| Infants under 12 months | Lower limit 4 mg/dL | Lower limit about 1.29 mmol/L | Lower limit in the label dosing table (Table 2 footnote); use the lab's neonatal range |
| Children 12 months and older | Lower limit 2.5 mg/dL | Lower limit about 0.81 mmol/L | Lower limit in the same label table; the lab's pediatric range governs |
Severity & critical values
| Level | Conventional | SI | What it means |
|---|---|---|---|
| Normal | 2.5–4.5 mg/dL | 0.81–1.45 mmol/L | Adult reference interval |
| Low (hypophosphatemia) | Below 2.5 mg/dL | Below 0.81 mmol/L | Below range. Refeeding and insulin treatment of DKA are the common ICU causes |
| DKA/HHS replacement threshold | Below about 3.1 mg/dL | Below 1.0 mmol/L | 2024 hyperglycemic crises consensus (Diabetologia text): routine replacement not indicated; consider it with muscle weakness, or respiratory or cardiac compromise. Follow local DKA protocol |
| Critical (low) | Below 1 mg/dL | Below 0.32 mmol/L | Typical lab-specific critical call. Weakness, respiratory failure or arrhythmia are the hazards |
| High (hyperphosphatemia) | Above 4.5 mg/dL | Above 1.45 mmol/L | Usually reduced kidney excretion or cell breakdown. Check creatinine, calcium and a clean repeat |
Critical values: Low phosphate below 1 mg/dL (0.32 mmol/L) is a typical critical call. Your lab's value rules. There is no universal high critical value, so the high call is lab-specific. Weakness or breathing trouble with a low value means act now. The exact number does not change that.
Conversion: mg/dL × 0.323 = mmol/L; mmol/L × 3.1 = mg/dL (1 mmol phosphorus = 31 mg).
Causes of Abnormal Results
Low (hypophosphatemia)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Shift into cells | Insulin therapy for DKA or HHS; glucose loading. Insulin drives phosphate into cells | Falls during treatment; check every 4 hr until resolved |
| Refeeding | Calories or dextrose restarted after starvation or poor intake | Falls within 5 days of restarting calories per ASPEN 2020; often with low K⁺ and Mg²⁺ |
| Poor intake | Prolonged starvation, anorexia, malnutrition | Weight loss and a long history of low intake |
| Chronic alcohol or drug use | Chronic alcohol or drug use disorder (listed as a refeeding risk factor by ASPEN) | Thiamin deficiency risk; check K⁺ and Mg²⁺ on the same draw |
| Respiratory alkalosis | Hyperventilation or overventilation shifts phosphate into cells | Low phosphate with high pH and low CO₂; check it on the same blood gas draw when possible |
| Vitamin D deficiency or hyperparathyroidism | Raised parathyroid hormone increases renal phosphate loss; vitamin D deficiency also reduces absorption | Slow, chronic fall; check calcium, vitamin D and PTH on routine work-up |
| CRRT or dialysis | Phosphate is removed with the solute during continuous or intermittent therapy | Check phosphate during therapy; depletion can impair respiratory muscle function and delay ventilator weaning |
Refeeding is the emergency: Low phosphate after feeding starts can hit the heart and the lungs. Check phosphate before the first calories or dextrose. Do not wait for symptoms.
High (hyperphosphatemia)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Reduced excretion | Kidney failure, AKI, oliguria, CKD | Rising creatinine and falling urine output. Phosphate rises as GFR falls |
| Cell breakdown | Rhabdomyolysis, tumor lysis | CK and potassium rise with it; see the rhabdomyolysis page |
| Phosphate load | IV phosphate products; phosphate-containing enemas | Check the product; a high level after a known phosphate dose is expected |
| Low calcium with high phosphate | Hypoparathyroidism | Low total or ionized calcium with the high phosphate |
| Pseudohyperphosphatemia | Hemolyzed or delayed-processing sample | Repeat on a clean sample before treating |
Do not treat a hemolyzed value: When the patient is well, repeat a high phosphate from a hemolyzed sample first. Do not make a phosphate-lowering or dialysis decision on that number alone.
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Check hemolysis and the time to processing. Repeat on a clean sample if the value does not fit the patient.
- How sick is the patient? Weakness, breathing effort, rhythm and mental status set urgency. The number matters less.
- Acute or chronic, and the trend. After insulin or feeding, a fall is acute. A steady rise with falling urine output points to kidney disease.
- Check K⁺, Mg²⁺ and calcium. Phosphate is replaced with them. Low K⁺ or Mg²⁺ makes replacement fail.
- Classify with named criteria. The ASPEN 2020 refeeding grades use percentage falls within 5 days of restarting calories. The 2024 DKA/HHS consensus sets the replacement threshold.
- Escalate or dispose. Replace per protocol and monitor. Refer to ICU for respiratory compromise, arrhythmia or a dialysis need.
Refeeding grades per ASPEN 2020
| Grade | Definition | Action |
|---|---|---|
| Mild | Fall of 10–20% in phosphorus, potassium or magnesium within 5 days of restarting calories | Replete; monitor per protocol |
| Moderate | Fall of 20–30% | Replete; reduce calories or dextrose by 50% if electrolytes are hard to correct |
| Severe | Fall above 30%, or organ dysfunction from the fall or from thiamin deficiency | Consider stopping nutrition support if lows are severe or life-threatening |
Phosphate action by setting
| Setting | What the source says |
|---|---|
| DKA or HHS | Routine phosphate is not indicated. Consider replacement below 1.0 mmol/L with muscle weakness, or respiratory or cardiac compromise (2024 consensus). The consensus notes 20–30 mmol may be added to fluids when needed; check any dose against the label's weight-based table |
| Refeeding | Check phosphate, K⁺ and Mg²⁺ before starting nutrition. Delay increases when levels are severely low until corrected per ASPEN 2020 |
| CRRT or dialysis | Phosphate is cleared with the solute; check and replace per protocol |
Management Priorities
Emergency: Low phosphate with weakness, breathing failure or cardiac compromise
- Stabilize: airway, breathing, cardiac monitor and a 12-lead ECG for arrhythmia.
- Check first: phosphate, K⁺, Mg²⁺ and calcium on a draw that is not delayed. Calcium must be normal before any phosphate is given, and potassium must be below 4 mEq/L (see the restriction box below).
- Replace only if no contraindication applies: IV potassium phosphate in fluid, weight-based per the label table below, under its rate limits. Do not give it in hyperkalemia, severe renal impairment or ESRD, hyperphosphatemia, or hypercalcemia or significant hypocalcemia.
- Monitor during and after: phosphate, calcium, K⁺ and Mg²⁺. With pulmonary distress, stop the infusion and get medical evaluation.
- Recheck: repeat phosphate and electrolytes on the protocol schedule.
Doses vary by protocol; follow local protocols and medical direction.
Medications
| Drug | Adult dose | Pediatric dose (max) | Onset / key notes |
|---|---|---|---|
| Potassium phosphates IV, in fluid (correction) | Single dose by serum phosphate, mmol/kg of actual body weight: 1.8 mg/dL up to the lower reference limit 0.16–0.31; 1–1.7 mg/dL 0.32–0.43; below 1 mg/dL 0.44–0.64. The lower limit is 2.5 mg/dL (4 mg/dL under 12 months). Max 45 mmol single dose. Moderate renal impairment (eGFR 30 to below 60): start at the low end. | Under 12 years: same mmol/kg dosing by actual body weight; 45 mmol is an upper ceiling only. No mmol/hr rate is given. Use the smallest recommended diluent volume within the maximum concentration: peripheral 0.27 mmol/10 mL, central 0.55 mmol/10 mL. Infants under 12 months: 4 mg/dL lower limit. Pediatric specialist input advised. | Dilute in 0.9% sodium chloride or 5% dextrose; ages 12 and older: 100 or 250 mL total volume. Maximum diluted concentration for ages 12 and older: 6.8 mmol/100 mL peripheral, 18 mmol/100 mL central. Ages 12 and older: peripheral max 6.8 mmol/hr (K 10 mEq/hr); central max 15 mmol/hr (K 22 mEq/hr). Continuous ECG and a central catheter above K 10 mEq/hr (or above 0.5 mEq/kg/hr under 20 kg). Do not infuse with calcium-containing fluids. High-alert |
| Potassium phosphates IV, parenteral nutrition | Adults and children 12 years and older: 20–40 mmol/day (low end if eGFR 30 to below 60) | Under 12 months: 2 mmol/kg/day. 1 to under 12 years: 1 mmol/kg/day, max 40 mmol/day | Only when oral or enteral phosphate is not feasible. High-alert |
High-alert potassium phosphate: Undiluted is never an option: the label sets the dilution and the maximum rate. Each mL holds 3 mmol phosphorus and 4.4 mEq potassium. Get an independent double-check, run it on a pump and keep the patient on cardiac monitoring.
Contraindicated in: hyperkalemia; severe renal impairment (eGFR below 30 mL/min/1.73 m²) or end-stage renal disease; hyperphosphatemia; hypercalcemia or significant hypocalcemia.
Potassium limit: Potassium comes first. Serum potassium has to be below 4 mEq/L before you use it. The label prints "4 mEq/dL" throughout, which is almost certainly a unit typo for mEq/L (normal potassium is about 3.5–5 mEq/L). Confirm it with pharmacy. If potassium is 4 or higher, pick another phosphate source.
Before every dose: Potassium and calcium get checked every time, and calcium gets normalized first. Calcium-containing IV fluids never share the line. Then read the med list, because potassium supplements, ACE inhibitors, ARBs and potassium-sparing diuretics all push potassium up. The label warns of hyperkalemia with drugs that raise potassium.
Definitive care & disposition
- Oral or enteral first: If the gut works, use it: oral or enteral phosphate. IV phosphate is the fallback, for when oral or enteral replacement is not possible, insufficient or contraindicated (label indication).
- Refeeding risk per ASPEN 2020: high risk if the patient meets at least one of: BMI below 16; unintentional weight loss above 15% in 3–6 months; little or no intake for more than 10 days; or low K⁺, phosphate or Mg²⁺ before feeding. Or at least two of: BMI below 18.5; weight loss above 10% in 3–6 months; little or no intake for more than 5 days; or history of alcohol or drug use, including insulin, chemotherapy, antacids or diuretics. In high-risk patients, start at 10–20 kcal/kg/day and advance over 4–7 days.
- Refeeding with low K⁺ or Mg²⁺: Calories wait. Hold or slow them until the electrolytes are corrected, per ASPEN 2020.
- DKA or HHS: Work the hyperglycemic-crisis protocol. Phosphate replacement follows the threshold above.
- High phosphate with kidney failure: This is a nephrology problem. Phosphate control (diet, binders) and dialysis decisions belong to them.
- ICU criteria: respiratory compromise, arrhythmia, altered mental status, or refeeding with organ dysfunction.
Doses are typical references. Follow local protocols, medical direction and institutional policy.
Field & Transport Considerations
Point-of-care testing
Phosphorus is a lab test. Before you assume a field analyzer reports it, check your device's test menu. Potassium, creatinine and glucose are the values that usually come from the field. So send the last phosphate result with its draw time.
Before and during interfacility transport
- Obtain: the last phosphate, K⁺, Mg²⁺, calcium and creatinine, with draw times, and any insulin, dextrose, feeding or dialysis since then.
- Treatments that change the value: Insulin, dextrose, restarted feeding and continuous dialysis all lower phosphate. IV phosphate raises it.
- Re-check cadence: per the receiving protocol. ASPEN 2020 suggests every 12 hours for the first 3 days in high-risk refeeding patients.
- Thiamin: Give it before dextrose-containing fluids or feeding in at-risk patients, per protocol.
- Delay or redirect: A low value with weakness or breathing failure is a transfer decision, made under medical direction. It is not a reason to start feeding.
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates & infants | ASPEN 2020 refeeding criteria cover children 28 days to 18 years | Check phosphate before feeding starts; pediatric IV dosing per the label mmol/kg table |
| Children & adolescents | IV dosing is weight-based; under 12 years has concentration limits | Dose by actual body weight (mmol/kg); 45 mmol is an upper ceiling only. Under 12: follow the label's maximum concentration limits. Infants under 12 months use the 4 mg/dL lower limit |
| CKD / dialysis | Phosphate rises as GFR falls; CRRT and dialysis lower it | KDIGO 2017 suggests lowering elevated phosphate toward the normal range (grade 2C); read it with calcium and PTH |
| Other | Chronic alcohol use and malnutrition raise refeeding risk per ASPEN 2020 | Replete K⁺, Mg²⁺ and phosphate; give thiamin before dextrose |
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Hemolysis | ↑ False + | Red cells release phosphate into the serum | Redraw cleanly; avoid traumatic draws |
| Delayed separation | ↑ False + | Phosphate leaves cells in unseparated blood | Separate and process promptly |
Medications & supplements
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Insulin and dextrose | ↓ Low | Phosphate moves into cells | Check during DKA or HHS treatment and after feeding restarts |
| IV potassium phosphate or phosphate enemas | ↑ High | Adds a phosphate load | Check the product before judging the level |
Physiologic & biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Malignancy | ↑ or ↓ False | Spurious electrolyte results are described in patients with cancer | Repeat on a clean sample; read the trend |
Assay & device-specific
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Lab method and units | Lab-specific | Methods and reference intervals differ between labs | Use the lab's own range and units |
Common misinterpretations
- A normal phosphate does not rule out depletion. Most body phosphate sits in bone and cells.
- A fall after insulin or dextrose is expected. The question is how fast it falls, and whether symptoms follow.
- IV replacement fixes the level. It does not fix the cause. Keep checking K⁺ and Mg²⁺.
- Do not call a high value from a hemolyzed sample kidney failure. Wait for a clean repeat to confirm it.
Physiology & Test Basics
What it measures
Serum phosphorus is inorganic phosphate (PO₄³⁻) in blood, reported as mg/dL or mmol/L. Keep in mind this page covers serum only. It sits with calcium and magnesium on the renal panel. It says nothing about phosphate stored in bone and cells.
Physiology & regulation
- Phosphate is part of ATP, cell membranes and bone.
- Depletion lowers 2,3-DPG. Hemoglobin then holds oxygen more tightly, so tissues get less, per ASPEN 2020.
- Insulin and glucose loading move phosphate into cells. Serum levels fall with them, per ASPEN 2020.
- Most phosphate leaves through the kidneys. As GFR falls, excretion falls too, and levels rise in kidney failure.
- Parathyroid hormone drives up renal phosphate loss.
How it is measured
- Serum, drawn in a red-top or gold (serum separator) tube. Separate it and process it promptly. Avoid hemolysis.
- A lab analyzer. Turnaround depends on the lab. In most settings this is not a bedside test.
- US labs report mg/dL. Many other countries report mmol/L.
Why it matters
Low phosphate weakens skeletal muscle, the diaphragm and the heart. Oxygen delivery to the tissues drops with it. In refeeding and DKA, the level can fall within days of restarting calories or starting insulin. One normal value drawn before a change in care does not clear the patient.
Clinical Pearls
Refeeding: Before calories or dextrose start in an at-risk patient, check phosphate, K⁺ and Mg²⁺. ASPEN 2020 suggests checking every 12 hours for the first 3 days in high-risk patients.
Thiamin first: Thiamin goes in before dextrose or feeding for any patient at risk of deficiency, per protocol. Deficiency can bring on Wernicke encephalopathy during refeeding.
DKA: a falling phosphate is expected: Insulin pulls it down. Check phosphate every 4 hours until resolution. Routine replacement is not indicated. Consider it below 1.0 mmol/L with weakness, or with cardiac or respiratory compromise (2024 consensus).
Transport: Send the last phosphate with its draw time, plus any insulin, dextrose, feeding or dialysis since then. The receiving team needs the trend. One value does not tell them enough.
Nursing: new weakness on insulin: New weakness or rising work of breathing in a patient on insulin? Add phosphate to the glucose and potassium check. Do not wait for the next scheduled draw.
IV potassium phosphate: Do not infuse it with calcium-containing IV fluids. Calcium-phosphate precipitates can cause pulmonary embolism. If respiratory distress develops, stop the infusion and evaluate. Normalize calcium before giving it. Monitor magnesium too. Hypomagnesemia is reported with hypercalcemia and DKA.
References
- Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, et al. (2024). Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care, 47(8), 1257–1275. https://pubmed.ncbi.nlm.nih.gov/39052901/. The phosphate statements were checked in the joint Diabetologia text, doi:10.1007/s00125-024-06183-8.
- da Silva JSV, Seres DS, Sabino K, et al. (2020). ASPEN consensus recommendations for refeeding syndrome. Nutrition in Clinical Practice, 35(2), 178–195. https://pubmed.ncbi.nlm.nih.gov/32115791/
- Caplin Steriles Limited. Potassium phosphates injection, USP (concentrate): prescribing information. DailyMed, set ID fbbd8380-9848-4862-8c73-2f53fcdf7120, version 2 (published 21 September 2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbbd8380-9848-4862-8c73-2f53fcdf7120
- KDIGO CKD-MBD Update Work Group. (2017). KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney International Supplements, 7(1), 1–59. https://pubmed.ncbi.nlm.nih.gov/30675420/
- Chowdhury R, Turcotte AE, Rondon-Berrios H, Workeneh BT. (2023). Spurious electrolyte and acid-base disorders in the patient with cancer: a review. American Journal of Kidney Diseases. doi:10.1053/j.ajkd.2023.01.441. https://pubmed.ncbi.nlm.nih.gov/36906215/
- Institute for Safe Medication Practices. ISMP list of high-alert medications in acute care settings (2018 posting; a newer posting was not checked). https://www.ismp.org/sites/default/files/attachments/2018-01/highalertmedications(1).pdf
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.